Healthpeak Properties, Inc. (NYSE:DOC) Stock Has Average Target Price of $22.10

Key Points

• Analyst consensus is “Hold”: Fourteen of 18 analysts rate Healthpeak Properties neutral, while four recommend buying. The average 12-month price target is $22.10, above the stock’s reported $20.11 price.
• Institutional ownership remains high: Hedge funds and other institutional investors own 93.57% of DOC, with several firms increasing their positions during the first and second quarters.
• Healthpeak exceeded quarterly expectations and offers a 6.1% yield: The REIT reported $0.08 in quarterly EPS versus a $0.03 consensus estimate and revenue of $771.58 million. Its monthly dividend is $0.1017 per share, or $1.22 annualized.

Shares of Healthpeak Properties, Inc. (NYSE:DOC - Get Free Report) have been assigned an average rating of "Hold" from the eighteen analysts that are currently covering the company, MarketBeat reports. Fourteen analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1-year price objective among analysts that have covered the stock in the last year is $22.10.

Several equities analysts have weighed in on DOC shares. Royal Bank Of Canada raised their target price on shares of Healthpeak Properties from $21.00 to $24.00 and gave the company an "outperform" rating in a report on Monday, August 10th. Morgan Stanley reaffirmed an "equal weight" rating and issued a $22.00 price target (up from $20.00) on shares of Healthpeak Properties in a report on Thursday, June 11th. Barclays increased their price target on shares of Healthpeak Properties from $23.00 to $24.00 and gave the company an "equal weight" rating in a research report on Monday, August 31st. Wells Fargo & Company raised their price objective on shares of Healthpeak Properties from $20.00 to $22.00 and gave the stock an "equal weight" rating in a research note on Wednesday, July 15th. Finally, Cantor Fitzgerald lifted their price objective on Healthpeak Properties from $20.00 to $23.00 and gave the stock a "neutral" rating in a research report on Thursday, August 6th.

Institutional Trading of Healthpeak Properties

Several institutional investors and hedge funds have recently made changes to their positions in DOC. OneDigital Investment Advisors LLC lifted its holdings in shares of Healthpeak Properties by 3.3% during the 2nd quarter. OneDigital Investment Advisors LLC now owns 15,376 shares of the real estate investment trust's stock valued at $329,000 after acquiring an additional 493 shares in the last quarter. Clearstead Trust LLC increased its holdings in Healthpeak Properties by 66.7% in the 2nd quarter. Clearstead Trust LLC now owns 1,357 shares of the real estate investment trust's stock valued at $29,000 after purchasing an additional 543 shares in the last quarter. CX Institutional increased its holdings in Healthpeak Properties by 6.1% in the 2nd quarter. CX Institutional now owns 11,003 shares of the real estate investment trust's stock valued at $235,000 after purchasing an additional 633 shares in the last quarter. Quantum Portfolio Management LLC raised its position in Healthpeak Properties by 2.5% in the first quarter. Quantum Portfolio Management LLC now owns 29,372 shares of the real estate investment trust's stock valued at $483,000 after purchasing an additional 728 shares during the period. Finally, Intrua Financial LLC raised its position in Healthpeak Properties by 1.1% in the first quarter. Intrua Financial LLC now owns 66,702 shares of the real estate investment trust's stock valued at $1,096,000 after purchasing an additional 744 shares during the period. 93.57% of the stock is currently owned by hedge funds and other institutional investors.

Healthpeak Properties Stock Up 0.1%

Healthpeak Properties stock opened at $20.11 on Wednesday. The company has a debt-to-equity ratio of 1.06, a quick ratio of 3.02 and a current ratio of 3.02. The firm has a market capitalization of $13.87 billion, a price-to-earnings ratio of 57.46, a price-to-earnings-growth ratio of 2.48 and a beta of 1.01. Healthpeak Properties has a fifty-two week low of $15.70 and a fifty-two week high of $22.95. The stock's fifty day moving average is $21.03 and its two-hundred day moving average is $19.71.

Healthpeak Properties (NYSE:DOC - Get Free Report) last released its quarterly earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.03 by $0.05. Healthpeak Properties had a return on equity of 2.79% and a net margin of 8.24%.The business had revenue of $771.58 million during the quarter, compared to the consensus estimate of $725.64 million. During the same quarter in the previous year, the company posted $0.46 EPS. The business's revenue was up 11.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. Analysts predict that Healthpeak Properties will post 1.77 EPS for the current fiscal year.

Healthpeak Properties Announces Dividend

The business also recently declared a monthly dividend, which was paid on Friday, September 25th. Shareholders of record on Monday, September 14th were given a dividend of $0.1017 per share. The ex-dividend date of this dividend was Monday, September 14th. This represents a $1.22 annualized dividend and a yield of 6.1%. Healthpeak Properties's dividend payout ratio (DPR) is presently 348.57%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc NYSE: DOC is a real estate investment trust that owns, develops, leases and manages healthcare-related properties in the United States. Its portfolio primarily includes outpatient medical office buildings, life science facilities and other properties designed to support healthcare providers, researchers and related businesses.

The company's outpatient medical office properties are generally located near hospitals and health systems and accommodate physicians, specialty clinics, ambulatory services and other healthcare users.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.